ARCT
Arcturus Therapeutics Holdings Inc.$15.81+0.52 (+3.40%)Prev Close$15.29·MCap$434.6M·P/E—·Vol415.1K·Yield0.05%
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$0.00
●
Active Insiders
0
last 12 mo
ARCT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | SASSINE ANDY | Chief Financial Officer | Sell | 1,238 | $16.56 | $20.5K | 0 |
| Oct 15, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 12,000 | $20.76 | $249.1K | 0 |
| Jun 12, 2024 | SASSINE ANDY | Chief Financial Officer | Sell | 50,000 | $32.03 | $1.60M | 0 |
| Jun 5, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 114 | $45.00 | $5.1K | 0 |
| Jun 3, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 26,000 | $40.01 | $1.04M | 0 |
| Mar 25, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 17,435 | $35.02 | $610.6K | 0 |
| Mar 19, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 8,565 | $35.01 | $299.8K | 0 |
| Nov 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $18.72 | $93.6K | 0 |
| Oct 2, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $25.61 | $128.1K | 0 |
| Sep 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $31.45 | $157.3K | 0 |
| Aug 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $34.91 | $174.6K | 0 |
| Jul 14, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 25,000 | $35.01 | $875.3K | 0 |
| Jul 14, 2023 | Kummerfeld Keith C | See Remarks | Sell | 6,968 | $35.00 | $243.9K | 0 |
| Jul 3, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $28.75 | $143.8K | 0 |
| Jun 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $27.16 | $135.8K | 0 |
| May 10, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 25,000 | $30.08 | $751.9K | 0 |
| May 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $25.93 | $129.7K | 0 |
| Apr 17, 2023 | Kummerfeld Keith C | See Remarks | Sell | 6,968 | $28.18 | $196.4K | 0 |
| Apr 3, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $25.38 | $126.9K | 0 |
| Mar 6, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $16.07 | $80.3K | 0 |
| Dec 15, 2022 | Marquet Magda | Director | Buy | 2,222 | $18.00 | $40.0K | 0 |
| Nov 23, 2022 | Payne Joseph E | President and CEO | Buy | 5,000 | $16.51 | $82.5K | 0 |
| Jan 4, 2022 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 8,100 | $40.00 | $324.0K | 0 |
| Dec 16, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 3,633 | $40.00 | $145.3K | 0 |
| Dec 8, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 6,367 | $40.00 | $254.7K | 0 |
| Nov 1, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 10,000 | $44.41 | $444.1K | 0 |
| Sep 1, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 20,000 | $50.11 | $1.00M | 0 |
| Aug 3, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 10,000 | $40.07 | $400.7K | 0 |
| Apr 1, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 10,000 | $42.95 | $429.5K | 0 |
| Mar 1, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 10,000 | $54.23 | $542.3K | 0 |
ARCT Insider Buying Activity
The following table shows recent insider purchases of Arcturus Therapeutics Holdings Inc. (ARCT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | Marquet Magda | Director | Buy | 2,222 | $18.00 | $40.0K | 0 |
| Nov 23, 2022 | Payne Joseph E | President and CEO | Buy | 5,000 | $16.51 | $82.5K | 0 |
ARCT Insider Selling Activity
The following table shows recent insider sales of Arcturus Therapeutics Holdings Inc. (ARCT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | SASSINE ANDY | Chief Financial Officer | Sell | 1,238 | $16.56 | $20.5K | 0 |
| Oct 15, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 12,000 | $20.76 | $249.1K | 0 |
| Jun 12, 2024 | SASSINE ANDY | Chief Financial Officer | Sell | 50,000 | $32.03 | $1.60M | 0 |
| Jun 5, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 114 | $45.00 | $5.1K | 0 |
| Jun 3, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 26,000 | $40.01 | $1.04M | 0 |
| Mar 25, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 17,435 | $35.02 | $610.6K | 0 |
| Mar 19, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 8,565 | $35.01 | $299.8K | 0 |
| Nov 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $18.72 | $93.6K | 0 |
| Oct 2, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $25.61 | $128.1K | 0 |
| Sep 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $31.45 | $157.3K | 0 |
| Aug 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $34.91 | $174.6K | 0 |
| Jul 14, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 25,000 | $35.01 | $875.3K | 0 |
| Jul 14, 2023 | Kummerfeld Keith C | See Remarks | Sell | 6,968 | $35.00 | $243.9K | 0 |
| Jul 3, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $28.75 | $143.8K | 0 |
| Jun 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $27.16 | $135.8K | 0 |
| May 10, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 25,000 | $30.08 | $751.9K | 0 |
| May 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $25.93 | $129.7K | 0 |
| Apr 17, 2023 | Kummerfeld Keith C | See Remarks | Sell | 6,968 | $28.18 | $196.4K | 0 |
| Apr 3, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $25.38 | $126.9K | 0 |
| Mar 6, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 5,000 | $16.07 | $80.3K | 0 |
| Jan 4, 2022 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 8,100 | $40.00 | $324.0K | 0 |
| Dec 16, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 3,633 | $40.00 | $145.3K | 0 |
| Dec 8, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 6,367 | $40.00 | $254.7K | 0 |
| Nov 1, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 10,000 | $44.41 | $444.1K | 0 |
| Sep 1, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 20,000 | $50.11 | $1.00M | 0 |
| Aug 3, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 10,000 | $40.07 | $400.7K | 0 |
| Apr 1, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 10,000 | $42.95 | $429.5K | 0 |
| Mar 1, 2021 | Chivukula Pad | Chief Scientific Officer & COO | Sell | 10,000 | $54.23 | $542.3K | 0 |
ARCT Insiders
Similar Stocks to ARCT
VRTX
Vertex Pharmaceuticals Incorporated
$513.52-1.17%
$132.26B
REGN
Regeneron Pharmaceuticals, Inc.
$772.87-2.63%
$83.21B
MRNA
Moderna, Inc.
$142.93-2.49%
$57.13B
RVMD
Revolution Medicines, Inc.
$204.47-0.31%
$44.15B
INSM
Insmed Incorporated
$119.56-4.63%
$28.05B
INCY
Incyte Corporation
$121.65-0.43%
$24.62B
UTHR
United Therapeutics Corporation
$500.44-0.42%
$21.10B
NBIX
Neurocrine Biosciences, Inc.
$150.44-4.31%
$15.71B